Eledon Pharmaceuticals (ELDN) EBT (2016 - 2017)
Historic EBT for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to -$3.9 million.
- Eledon Pharmaceuticals' EBT rose 6616.49% to -$3.9 million in Q1 2017 from the same period last year, while for Mar 2017 it was -$30.4 million, marking a year-over-year increase of 2971.82%. This contributed to the annual value of -$36.0 million for FY2024, which is 6920.32% up from last year.
- According to the latest figures from Q1 2017, Eledon Pharmaceuticals' EBT is -$3.9 million, which was up 6616.49% from -$3.7 million recorded in Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' EBT registered a high of -$3.7 million during Q4 2016, and its lowest value of -$13.5 million during Q2 2016.
- Over the past 5 years, Eledon Pharmaceuticals' median EBT value was -$7.7 million (recorded in 2014), while the average stood at -$8.3 million.
- As far as peak fluctuations go, Eledon Pharmaceuticals' EBT plummeted by 17357.13% in 2015, and later skyrocketed by 6616.49% in 2017.
- Quarter analysis of 5 years shows Eledon Pharmaceuticals' EBT stood at -$5.5 million in 2013, then fell by 11.88% to -$6.2 million in 2014, then plummeted by 77.46% to -$11.0 million in 2015, then surged by 66.08% to -$3.7 million in 2016, then dropped by 3.45% to -$3.9 million in 2017.
- Its EBT stands at -$3.9 million for Q1 2017, versus -$3.7 million for Q4 2016 and -$9.3 million for Q3 2016.